JPMorgan analyst James Gordon raised the firm’s price target on Argenx to EUR 500 from EUR 480 and keeps an Overweight rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ARGX:
- Argenx included on Wells Fargo’s Tactical Ideas List for Q1 2023
- Wells Fargo upgrades Immunovant to Overweight, raises price target to $27
- argenx to Present at 41st Annual J.P. Morgan Healthcare Conference
- Argenx price target raised to $478 from $471 at Stifel
- Piper recommends ‘down market cap’ biotech exposure for 2023